283 related articles for article (PubMed ID: 23419679)
1. Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy.
Reinders ME; Roemeling-van Rhijn M; Khairoun M; Lievers E; de Vries DK; Schaapherder AF; Wong SW; Zwaginga JJ; Duijs JM; van Zonneveld AJ; Hoogduijn MJ; Fibbe WE; de Fijter JW; van Kooten C; Rabelink TJ; Roelofs H
Cytotherapy; 2013 Jun; 15(6):663-72. PubMed ID: 23419679
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of the biological characteristics of mesenchymal stem cells from bone marrow and peripheral blood of rats.
Fu WL; Zhang JY; Fu X; Duan XN; Leung KK; Jia ZQ; Wang WP; Zhou CY; Yu JK
Tissue Eng Part A; 2012 Sep; 18(17-18):1793-803. PubMed ID: 22721583
[TBL] [Abstract][Full Text] [Related]
3. Isolation of mesenchymal stem cells from shoulder rotator cuff: a potential source for muscle and tendon repair.
Tsai CC; Huang TF; Ma HL; Chiang ER; Hung SC
Cell Transplant; 2013; 22(3):413-22. PubMed ID: 23006509
[TBL] [Abstract][Full Text] [Related]
4. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.
Larghero J; Farge D; Braccini A; Lecourt S; Scherberich A; Foïs E; Verrecchia F; Daikeler T; Gluckman E; Tyndall A; Bocelli-Tyndall C
Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.
Bocelli-Tyndall C; Bracci L; Spagnoli G; Braccini A; Bouchenaki M; Ceredig R; Pistoia V; Martin I; Tyndall A
Rheumatology (Oxford); 2007 Mar; 46(3):403-8. PubMed ID: 16920750
[TBL] [Abstract][Full Text] [Related]
6. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
Heeschen C; Lehmann R; Honold J; Assmus B; Aicher A; Walter DH; Martin H; Zeiher AM; Dimmeler S
Circulation; 2004 Apr; 109(13):1615-22. PubMed ID: 15037527
[TBL] [Abstract][Full Text] [Related]
7. Investigating the efficacy of amnion-derived compared with bone marrow-derived mesenchymal stromal cells in equine tendon and ligament injuries.
Lange-Consiglio A; Tassan S; Corradetti B; Meucci A; Perego R; Bizzaro D; Cremonesi F
Cytotherapy; 2013 Aug; 15(8):1011-20. PubMed ID: 23602577
[TBL] [Abstract][Full Text] [Related]
8. Human mesenchymal stem cells derived from adipose tissue reduce functional and tissue damage in a rat model of chronic renal failure.
Villanueva S; Carreño JE; Salazar L; Vergara C; Strodthoff R; Fajre F; Céspedes C; Sáez PJ; Irarrázabal C; Bartolucci J; Figueroa F; Vio CP
Clin Sci (Lond); 2013 Aug; 125(4):199-210. PubMed ID: 23480877
[TBL] [Abstract][Full Text] [Related]
9. Influence of mesenchymal stem cells derived from bone marrow of children with oncohematological diseases on proliferation and self-renewal of hematopoietic progenitor cells in vitro.
Isaikina Y; Shman T
Exp Oncol; 2008 Jun; 30(2):121-8. PubMed ID: 18566575
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stromal cells isolated from children with systemic juvenile idiopathic arthritis suppress innate and adaptive immune responses.
Calkoen FG; Brinkman DM; Vervat C; van Ostaijen-Ten Dam MM; Ten Cate R; van Tol MJ; Ball LM
Cytotherapy; 2013 Mar; 15(3):280-91. PubMed ID: 23312448
[TBL] [Abstract][Full Text] [Related]
11. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study.
Duijvestein M; Vos AC; Roelofs H; Wildenberg ME; Wendrich BB; Verspaget HW; Kooy-Winkelaar EM; Koning F; Zwaginga JJ; Fidder HH; Verhaar AP; Fibbe WE; van den Brink GR; Hommes DW
Gut; 2010 Dec; 59(12):1662-9. PubMed ID: 20921206
[TBL] [Abstract][Full Text] [Related]
12. Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.
Payne NL; Sun G; McDonald C; Layton D; Moussa L; Emerson-Webber A; Veron N; Siatskas C; Herszfeld D; Price J; Bernard CC
Cell Transplant; 2013; 22(8):1409-25. PubMed ID: 23057962
[TBL] [Abstract][Full Text] [Related]
13. Effects of hepatocyte growth factor overexpressed bone marrow-derived mesenchymal stem cells on prevention from left ventricular remodelling and functional improvement in infarcted rat hearts.
Wang S; Qin X; Sun D; Wang Y; Xie X; Fan W; Wang Y; Liang D; Pei X; Cao F
Cell Biochem Funct; 2012 Oct; 30(7):574-81. PubMed ID: 22592978
[TBL] [Abstract][Full Text] [Related]
14. Phenotypical and functional characterization of bone marrow mesenchymal stem cells in patients with chronic graft-versus-host disease.
Wang B; Hu Y; Liu L; Hu K; Tie R; He Y; Fu S; Zhu N; Luo Y; Yu X; Huang H
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1020-8. PubMed ID: 25708216
[TBL] [Abstract][Full Text] [Related]
15. Presence of osteoclast precursor cells during ex vivo expansion of bone marrow-derived mesenchymal stem cells for autologous use in cell therapy.
Allers C; Lasala GP; Minguell JJ
Cytotherapy; 2014 Apr; 16(4):454-9. PubMed ID: 24176545
[TBL] [Abstract][Full Text] [Related]
16. Cell therapy with autologous mesenchymal stem cells-how the disease process impacts clinical considerations.
Wang J; Liao L; Wang S; Tan J
Cytotherapy; 2013 Aug; 15(8):893-904. PubMed ID: 23751203
[TBL] [Abstract][Full Text] [Related]
17. Impact of lenalidomide on the functional properties of human mesenchymal stromal cells.
Wobus M; Benath G; Ferrer RA; Wehner R; Schmitz M; Hofbauer LC; Rauner M; Ehninger G; Bornhäuser M; Platzbecker U
Exp Hematol; 2012 Oct; 40(10):867-76. PubMed ID: 22705469
[TBL] [Abstract][Full Text] [Related]
18. Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy.
Haack-Sorensen M; Friis T; Bindslev L; Mortensen S; Johnsen HE; Kastrup J
Scand J Clin Lab Invest; 2008; 68(3):192-203. PubMed ID: 17852829
[TBL] [Abstract][Full Text] [Related]
19. Growth kinetics and self-renewal of human mesenchymal stem cells derived from bone marrow of children with oncohematological diseases during expansion in vitro.
Isaikina Y; Kustanovich A; Svirnovski A
Exp Oncol; 2006 Jun; 28(2):146-51. PubMed ID: 16837907
[TBL] [Abstract][Full Text] [Related]
20. Human peripheral blood derived mesenchymal stem cells demonstrate similar characteristics and chondrogenic differentiation potential to bone marrow derived mesenchymal stem cells.
Chong PP; Selvaratnam L; Abbas AA; Kamarul T
J Orthop Res; 2012 Apr; 30(4):634-42. PubMed ID: 21922534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
